Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Takara Bio and CAMS to codevelop cancer immunotherapies in China

Sep. 9, 2004

Positive interim results from phase II trials of TroVax

Sep. 3, 2004

Antitumor efficacy of ABX-EGF in metastatic renal cancer

Sep. 1, 2004

Aphton seeks Canadian registration of Insegia in pancreatic cancer

Aug. 30, 2004

SGN-40 receives orphan drug designation for multiple myeloma

Aug. 26, 2004

Medarex reaches SPA agreement for phase III trial of MDX-010

Aug. 26, 2004

Orphan drug status for HuMax-CD4

Aug. 24, 2004

Viragen updates Multiferon progress

Aug. 24, 2004

Bispecific antibody targets EGFR-positive bile duct carcinoma

Aug. 19, 2004

New phase II study for HuMax-CD4 in non-cutaneous T-cell lymphoma

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026